
miRecule
Gaithersburg, MD, United States · mirecule.com
miRecule is a biotechnology company in Gaithersburg, Maryland developing RNA therapeutics for cancer, muscular dystrophy, and other rare genetic diseases. It uses genomic and outcome data to design tissue-targeted RNA medicines, including antibody RNA conjugate approaches and peptide-mediated delivery technologies.
Their website has a general contact form; we send your quote request through it.
What they offer
DREAmiR™ discovery platform
Uses genomic and outcome data from patients to identify disease-causing genetic changes and design RNA therapeutics that target them.
Genomics Discovery Engine
Integrates genomic sequencing profiles and clinical outcome measures to identify RNA therapeutic targets, then filters them through a high-throughput in vitro screen.
Patented RNA Chemistry
Develops chemically modified RNA sequences intended to improve stability, potency, and safety.
Targeted Delivery
Uses antibody-based delivery formulations to direct RNA therapeutics to diseased tissues such as tumors and muscle.
Antibody RNA Conjugate (ARC) therapeutics
Develops targeted RNA therapeutics that combine antibody-based tissue targeting with RNA payloads.
Peptide-mediated delivery technologies
Develops peptide delivery approaches for targeted delivery of RNA therapeutics to extra-hepatic tissues.
What they work on
- Modalities
- Antibody, Peptide, Oligonucleotide
- Assays and studies
- high-throughput in vitro screen
- Scale and capacity
- up to three targets
- Therapeutic areas
- cancer, muscular dystrophy, neuromuscular diseases, rare genetic diseases, rare diseases
- Sites
- Gaithersburg, United States
- Serves
- global markets
- Address
- 704 Quince Orchard Road Gaithersburg, MD 20878
Similar labs. Syngene International Ltd, Ansa Biotechnologies, AtlasXomics, Clevergene
Found in a contract services directory. Listing built from mirecule.com. Work here? Claim this listing.